No black box warning on record for Veltassa

As of the latest FDA labeling reviewed, Veltassa (PATIROMER) does not carry a black box warning. Standard warnings and precautions still apply — see the full Veltassa medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Worsening of Gastrointestinal Motility. ( 5.1 ) Hypomagnesemia. ( 5.2 ) 5.1 Worsening of Gastrointestinal Motility Avoid use of Veltassa in patients with severe constipation, bowel obstruction or impaction, including abnormal post-operative bowel motility disorders, because Veltassa may be ineffective and may worsen gastrointestinal conditions. Patients with a history of

No black box warning on record for Veltassa

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Worsening of Gastrointestinal Motility. ( 5.1 ) Hypomagnesemia. ( 5.2 ) 5.1 Worsening of Gastrointestinal Motility Avoid use of Veltassa in patients with severe constipation, bowel obstruction or impaction, including abnormal post-operative bowel motility disorders, because Veltassa may be ineffective and may worsen gastrointestinal conditions. Patients with a history of

Veltassa Black Box Warning

No black box warning on record for Veltassa

Other warnings & precautions

Veltassa Black Box Warning

No black box warning on record for Veltassa

Other warnings & precautions